News & Updates
Filter by Specialty:

Oestradiol patches bump up ADT armamentarium for prostate cancer
04 Mar 2025
byAudrey Abella
Findings from a phase II trial demonstrate the potential of transdermal oestradiol (tE2) patches as androgen deprivation therapy (ADT) for men with metastatic (M1) prostate cancer who are on androgen receptor pathway inhibitors (ARPI).
Oestradiol patches bump up ADT armamentarium for prostate cancer
04 Mar 2025
Real-world data support FTD/TPI plus bevacizumab for mCRC
03 Mar 2025
byAudrey Abella
A combination regimen comprising trifluridine/tipiracil (FTD/TPI) and bevacizumab demonstrates favourable efficacy and safety in individuals with metastatic colorectal cancer (mCRC) in the real-world BeTAS study presented at ASCO GI 2025.